Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2003

01-11-2003

p53 Inactivation is a Rare Event in Familial Breast Tumors Negative for BRCA1 and BRCA2 Mutations

Authors: Elisa Sensi, Mariella Tancredi, Paolo Aretini, Giovanna Cipollini, A. Giuseppe Naccarato, Paolo Viacava, Generoso Bevilacqua, Maria A. Caligo

Published in: Breast Cancer Research and Treatment | Issue 1/2003

Login to get access
Metadata
Title
p53 Inactivation is a Rare Event in Familial Breast Tumors Negative for BRCA1 and BRCA2 Mutations
Authors
Elisa Sensi
Mariella Tancredi
Paolo Aretini
Giovanna Cipollini
A. Giuseppe Naccarato
Paolo Viacava
Generoso Bevilacqua
Maria A. Caligo
Publication date
01-11-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/B:BREA.0000003836.91844.b5

Other articles of this Issue 1/2003

Breast Cancer Research and Treatment 1/2003 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine